Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-30T21:53:06.846Z Has data issue: false hasContentIssue false
  • English
  • Français

Hospital microbiology laboratory practices for Enterobacteriaceae: Centers for Disease Control and Prevention National Healthcare Safety Network (NHSN) annual survey, 2015 and 2016

Published online by Cambridge University Press:  24 July 2018

Alicia Shugart ,
Maroya Spalding Walters Open the ORCID record for Maroya Spalding Walters [Opens in a new window] ,
Lindsey M. Weiner ,
David Lonsway  and
Alexander J. Kallen
Alicia Shugart*
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Maroya Spalding Walters
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Lindsey M. Weiner
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
David Lonsway
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Alexander J. Kallen
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
*
Author for correspondence: Alicia Shugart, Centers for Disease Control and Prevention, Roybal Campus, 1600 Clifton Road, MS A31, Atlanta, GA 30329. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

We analyzed clinical microbiology laboratory practices for detection of multidrug-resistant Enterobacteriaceae in US short-stay acute-care hospitals using data from the National Healthcare Safety Network (NHSN) Annual Facility Survey. Half of hospitals reported testing for carbapenemases, and 1% performed routine polymyxin susceptibility testing using reference broth microdilution.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 39 , Issue 9 , September 2018 , pp. 1115 - 1117
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION: Similar data for calendar years 2014 and 2015 have been presented: Shugart A, Weiner LM, Lonsway D, et al. Hospital Microbiology Laboratory Practices: CDC NHSN Annual Survey, 2014 and 2015. In addition, an oral presentation of these data was given at the SHEA Annual Conference 2017 on March 29, 2017, in St Louis, Missouri.

Cite this article: Shugart A, et al. (2018). Hospital microbiology laboratory practices for Enterobacteriaceae: Centers for Disease Control and Prevention National Healthcare Safety Network (NHSN) annual survey, 2015 and 2016. Infection Control & Hospital Epidemiology 2018, 39, 1115–1117. doi: 10.1017/ice.2018.153

References

1. National Healthcare Safety Network (NHSN) patient safety component – annual hospital survey. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/forms/57.103_pshospsurv_blank.pdf. Published January 2016. Accessed October 23, 2017.Google Scholar
2. Weiner, LM, Webb, AK, Walters, MS, et al. Policies for controlling multidrug-resistant organisms in US healthcare facilities reporting to the National Healthcare Safety Network. Infect Control Hosp Epidemiol 2016;37:1105–1108.Google Scholar
3. Clinical Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (June 2010 Update). Wayne PA: CLSI; 2010. CLSI document M100-S20-U.Google Scholar
4. Alert: antimicrobial susceptibility testing. Infectious Diseases Society of America website. https://www.idsociety.org/Topics_of_Interest/Antimicrobial_Resistance/Professionals/Antimicrobial_Susceptibility_Testing/. Published January 2011. Accessed December 28, 2017.Google Scholar
5. Antibiotic Resistance Lab Network: about the AR Lab Network. Centers for Disease Control and Prevention website. https://www.cdc.gov/drugresistance/solutions-initiative/ar-lab-networks.html. Published August 9, 2017. Accessed December 28, 2017.Google Scholar
6. Revell, P, Doern, C, Schuetz, A, and ASM’s Public and Scientific Affairs Board Committee on Laboratory Practices in Microbiology. White Paper on the Emergence of mcr-1 plasmid-mediated colistin resistance. American Society for Microbiology website. https://www.asm.org/index.php/public-policy/93-policy/94613-colistinres-10-16. Published October 3, 2016. Accessed October 23, 2017.Google Scholar
7. Hindler, JA, Humphries, RM. Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant gram-negative bacilli. J Clin Microbiol 2013;55:1678–1684.Google Scholar